Measuring Revenue Streams and Profitability for HIV Drugs
West, Darrell M.; Schneider, Jake | April 2018
Abstract
In this report, we estimate revenue streams and profitability for HIV drug treatments. In particular, we compile information regarding HIV disease prevalence and incidence rates, antiretroviral therapy (ART) coverage, future population growth, and drug prices. This material allows us to estimate the revenue streams available to drug-makers. Our research focuses on the six most populous sub-Saharan and North African nations (Democratic Republic of Congo, Egypt, Ethiopia, Nigeria, South Africa, and Tanzania) as well as potential returns for investment in Africa, the Middle East, and the world as a whole. This paper is the latest in a series of publications under the Brookings Private Sector Global Health R&D Project. Past reports examined health governance capacity, private funding levels, rate of return on investment, and barriers to private investment.
Citation
West, Darrell M.; Schneider, Jake. 2018. Measuring Revenue Streams and Profitability for HIV Drugs. © Brookings India. http://hdl.handle.net/11540/8279.Keywords
Health Care Financing
Financial Security
Financial Assistance
Aged Health
Health Care System
Health Care Policy
Access to Health Care
Public Expenditure
Insurance Companies
Fiscal Administration
Medical Costs
Aid Financing
Pension Funds
Medical Costs
Health Costs
Rural Population
Urban Population
Public Health Finance
Health Financing
Health Care Financing
Financial Policy
Health Sector Reform
Health Care Cost Control
Multiemployer pension plans
Keogh plans
Individual retirement accounts
Pension plans
Employee pension trusts
Pension trusts
Nursing homes
Long-term care facilities
Hospices
Accounts payable
Vouchers
Insurance carriers
Show allCollapse